Onemednet Corp (ONMD) is not a strong buy at this moment for a beginner investor with a long-term focus. The stock shows no significant trading trends, lacks positive news catalysts, and has weak financial performance. While technical indicators are neutral, there is no strong signal to suggest immediate entry.
The MACD is above 0 and positively contracting, indicating slight bullish momentum, but the RSI is neutral at 54.595. The stock is trading near its pivot at 0.75, with resistance at 0.847 and support at 0.653. Overall, the technical indicators do not provide a strong buy signal.
Revenue increased by 24.65% YoY in Q3 2025, showing some growth potential.
Net income dropped by 63.99% YoY, EPS fell by 85.71%, and gross margin remains negative at -125.42%. No recent news or significant trading trends from hedge funds, insiders, or Congress.
In Q3 2025, revenue increased to $177,000 (up 24.65% YoY), but net income dropped to -$741,000 (down 63.99% YoY). EPS fell to -0.01 (down 85.71% YoY), and gross margin remains deeply negative at -125.42%.
No data available on analyst ratings or price target changes.
